BIBLIOGRAPHY (cumulative IF 340, GOOGLE SCHOLAR H-FACTOR 39)

Articles with citation data:                                                          105

Number of citations  till November 2018 (no self cites)        3.060

Citations per publication                                                            27.3

Citations per year                                                                        122

H-Index (researchgate)                                                               38.6

Source: Institute for Scientific Information, http://www.isiknowledge.com and Researchgate.com

Publications

1.    Buters J, and Reichen J:  Sex difference in antipyrine 3-hydroxylation.  An in vivo/in vitro correlation of antipyrine metabolism in two rat strains.  Biochem. Pharmacol.  40: 771-777, 1990. (IF 3.58)
2.    Reichen J, Buters J, Sojcic Z, and Roos FJ:  Abnormal lipid composition of microsomes from cirrhotic rat liver—Does it contribute to decreased microsomal function?  Experientia 48: 482-486, 1992. (IF 0.3)
3.    Buters J, Reichen J, and Zysset T:  Metabolism of antipyrine in two rat models of liver cirrhosis.  Biochem. Pharmacol. 46: 983-991, 1993. (IF 3.58)
4.    Buters J, Schiller CD, and Chou RC:  A highly sensitive tool for assaying cytochrome P450 enzyme activity in rat, dog, and man:  Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin.  Biochem. Pharmacol.  46: 1577-1584, 1993. (IF 3.58)
5.    Buters J, Korzekwa KR, Kunze KL, Omata Y, Hardwick JP, and Gonzalez FJ: cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.  Drug Metab. Disp.  22: 688-692,1994. (IF 3.67)
6.    Koley AP, Buters J, Robinson RC, Markowitz A, and Friedman FK: CO binding kinetics of human cytochrome P450 3A4: Specific interactions of substrates with kinetically distinguishable conformers. J. Biol. Chem.  270: 5014-5018, 1995. (IF 5.81)
7.    Buters J, Shou M, Hardwick JP, Korzekwa KR, and Gonzalez FJ: cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus: Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution without purification. Drug Metab. Disp. 23: 696-701, 1995. (IF 3.67)
8.    Crespi CL, Steimel DT, Penman BW, Fernandez-Salguero P, Buters J, Gelboin HV, Gonzalez FJ, and Daly A: Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374.  Pharmacogenetics 5: 234-243, 1995. (IF 7.22)
9.    Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters J, Gudas JM, and Bates SE: Normal P53 status and function despite the development of drug resistance in human breast cancer cells. Cell Growth Diff. 6:  1395-1403, 1995. (IF 4.76)
10.    Grogan J, Shou M, Andrusiak EA, Tamura S, Buters J, Gonzalez FJ, and Korzekwa KR: Cytochrome P450 2A1, 2E1, and 2C9 cDNA-expression by insect cells and partial purification using hydrophobic chromatography. Biochem. Pharmacol. 50: 1509-1515, 1995. (IF 3.58)
11.    Gelboin HV, Krausz KW, Goldfarb I, Buters J, Yang SK, Gonzalez FJ, Korzekwa KR and Shou M: Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4. Biochem. Pharmacol. 50: 1841-1850, 1995. (IF 3.58)
12.    Lee SST, Buters J, Pineau T, and Gonzalez FJ: The role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem. 271: 12063-12067, 1996. (IF 5.81)
13.    Buters J, Tang BK, Pineau T, Gelboin HV, Kimura S., and Gonzalez FJ: Role of CYP1A2 in caffeine pharmacokinetics and metabolism: Studies using mice deficient in CYP1A2. Pharmacogenetics 6: 291-296, 1996. (IF 7.22)
14.    Shou M, Korzekwa KR, Krausz KW, Buters J, Grogan J, Goldfarb I, Hardwick JP, Gonzalez FJ, and Gelboin HV: Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Mol. Carcinog. 17:  241-249, 1996. (IF 4.47)
15.    Koley AP, Buters J, Robinson RC, Markowitz A, and Friedman FK: Interaction of polycyclic aromatic hydrocarbons with human cytochrome P450 1A1: A flash photolysis study. Arch. Biochem. Biophys. 336: 261-267, 1996. (IF 2.97)
16.    Bourdi M, Chen W, Peter RM, Martin JL, Buters JT, Nelson SD, and Pohl LR:  Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis, Chem. Res. Toxicol 9:1159-66, 1996. (IF 3.16)
17.    Geyer HJ, Schramm K. W., Scheunert I, Schughart K., Buters J, Wurst W, Greim H, Kluge R, Steinberg CEW, Kettrup A, Madhukar B, Olson JR, and Gallos MA Considerations on genetic and environmental factors that contribute to resistance or sensitivity of mammals including humans to toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCCD) and related compounds. Part 1: Genetic factors affecting the toxicity of TCDD. Ecotoxicology and Environmental Safety 36: 213-230, 1997. (IF 2.00)
18.    Chen L, Buters J, Hardwick JP, Tamura S, Penman BW, Gonzalez FJ, and Crespi CL: Coexpression of cytochrome P4502A6 and NADPH oxidoreductase in baculovirus system. Drug Metab. Disp. 25: 399-405, 1997. (IF 3.64)
19.    Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters J, Fojo T, and Poruchynsky MS: Paclitaxel-resistant human ovarian cancer cells have mutant ß-tubulins that exhibit impaired paclitaxel-driven polymerization. J. Biol. Chem. 272: 17118-17125, 1997. (IF 5.81)
20.    Koley AP, Buters J, Robinson RC, Markowitz A, and Friedman FK: Differential mechanisms of cytochrome P450 inhibition and activation by alpha-naphthoflavone, J. Biol. Chem. 272: 3149-52, 1997. (IF 5.81)
21.    Yang TJ, Krausz KW, Shou M, Yang SK,  Buters J,  Gonzalez FJ, and Gelboin HV: Inhibitory monoclonal antibody to human cytochrome P450 2B6. Biochem. Pharmacol. 55: 1633-1640, 1998. (IF 3.58)
22.    Zaher H, Buters J, Ward JM, Bruno MK, Lucas AM, Stern ST, Cohen SD, and Gonzalez FJ: Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol. Appl. Pharmacol. 152: 193-199, 1998. (IF 4.72)
23.    Buters J, Doehmer J, and Gonzalez FJ: Cytochrome P450-null mice. Drug Metab. Rev. 31: 437-447, 1999. (IF 3.64)
24.    Doehmer J, Buters J, Luch A., Soballa V, Baird WM, Morisson H, Stegeman JJ, Townsend AJ, Greenlee WF, Glatt HR, Seidel A, Jacob J, and Greim H: Molecular studies on the toxifying effects by genetically engineered cytochromes P450. Drug. Metab. Rev. 31: 433-435, 1999. (IF 3.64)
25.    Buters J, Sakai S, Pineau T, Alexander DL, Doehmer J, Ward J, Jefcoate CR, and Gonzalez FJ: The cytochrome P450 1B1- null mouse is resistant to -dimethylbenz[a]anthracene induced carcinogenesis. Proc. Natl. Acad. Sci. USA 96: 1977-1982, 1999. (IF 9.64)
26.    Heidel SM, Holston K, Buters J, Gonzalez FJ,Jefcoate CR, and Czuprynski CJ: Bone marrow stromal cell cytochrome P450 1B1 is required for preB cell apoptosis induced by 7,12-dimethylbenz[a]anthracene. Mol. Pharmacol. 56: 1317-1323, 1999. (IF 4.47)
27.    Heidel SM, MacWilliams PS, Baird WM, Dashwood,WM, Buters JT, Gonzalez FJ, Larsen MC, Czuprynski CJ, and Jefcoate CR: Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene. Cancer Res. 60:3454-60, 2000. (IF 7.66)
28.    Krausz KW, Goldfarb I, Buters J, Yang TJ, Gonzalez FJ, Gelboin HV: Monoclonal antibodies specific and inhibitory to human cytochromes P450 2B8, 2C9, and 2C19. Drug Metabol. Dispos. 29, 1410-1423, 2001. (IF 3.64)
29.    Luch A, Mahadevan B, Baird MB, Doehmer J, Seidel A, Glatt H, Greim H, Buters J: The role of cytochrome P450 1B1 in dibenzo[a,l]pyrene-induced carcinogenesis. Polycycl Aromat Compds 2001 (IF 0.77)
30.    Labedzki A, Buters J, Jabrane W, Fuhr U: Differences in caffeine and paraxanthin metabolism between human and murine CYP1A2. Biochem Pharmacol  63, 2159-67, 2002. (IF 3.58)
31.    Buters J, Mahavedan B, Quintanilla-Fendt L, Baird W, Luch A: Cytochrome P450 CYP1B1 mediates the carcinogenic potential of dibenzo[a,l]pyrene in mice and probably also humans. Chem Res Toxicol  15, 1127-1135, 2002. (IF 3.16)
32.    Buters J, Quintanilla-Martinez L, Schober W, Soballa VJ, Hintermair J, Wolff T, Gonzalez FJ, Greim H: CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a]anthracene-induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicity. Carcinogenesis 2003;24:327-34. (IF 5.37)
33.    Werner C, Raivich G, Cowen M, Sillaber I, Buters J, Spanagel R, Hofmann F: Importance of NO/cGMP signaling via cGMP-dependent protein kinase II for controlling emotionality and neurobehavioural effects of alcohol. Eur J Neuroscience 12, 3498-3506, 2004. (IF 3.71)
34.    Schober W, Lemmen C, Ring J, Behrendt H, Buters J: Dieselrußpartikel in der Modulation der allergischen Reaktion. Med Report 24, ISSN 0934-3148: 2, 2004. (IF 0.3)
35.    Lemmen C, Schober W, Buters J, Behrendt H: Dieselruß und Allergien. Allergo Journal 13, 311-322, 2004. (IF 0.3)
36.    Schober W, Belloni B, Lubitz S, Eberlein-Koenig B, Bohn P, Saritas Y, Lintelmann J, Matuschek G, Behrendt H, Buters J: Organic extracts of urban aerosol (PM2.5) enhance rBet v 1-induced upregulation of CD63 in basophils from birch pollen allergic individuals. Toxicol Sci 90, 377- 384, 2006. (IF 3.60)
37.    Buters J: Effective strategies for tumors affecting chemopreventive metabolism. Clin Cancer Res 12 (24), 7203-04, 2006. (IF 6.18)
38.    Seiss M, Nitz S, Kleinsasser N, Buters J, Behrendt H, Hickel R, Reichl FX: Identification of 2,3-epoxymethacrylic acid as an intermediate in the metabolism of dental materials in human liver microsomes. Dent Matter 23, 9-16, 2007. (IF 2.38)
39.    Buters J, Schober W, Gutermuth J, Jakob T, Aguilar-Pimentel A, Huss-Marp J, Traidl-Hoffmann C, Mair S, Mair S, Mayer F, Breuer B and Heidrun Behrendt H: Toxicity of parked motor vehicle indoor air. Environ Sci Tech 41, 2622-9, 2007. (IF 4.36)
40.    Schober W, Lubitz S, Belloni B, Gebauer G, Lintelmann J, Matuschek G, Weichenmeier I, Eberlein-König B, Buters J, Behrendt H: Environmental polycyclic aromatic hydrocarbons (PAHs) enhance allergic inflammation by acting on human basophils. 10th INIS Monographs: Inhalation Toxicology 19, 151-156, 2007. (IF 2.17)
41.    Buters J, Kasche A, Weichenmeier I, Schober W, Klaus S, Traidl-Hoffmann C, Menzel A, Huss-Marp J, Krämer U and Behrendt H: Year-to-year variation in release of Bet v 1 allergen from birch pollen: evidence for geographical differences between west and south Germany. Int Arch Allergy Immunol 145,122-130, 2008. (IF 2.7)
42.    Buters J. Phase I metabolism. In „Toxicology & risk assessment. A comprehensive introduction“. pp 49-74. Eds. H. Greim and R. Snyder. West Sussex, Wiley, 2008 (IF 0.3)
43.    Singh AP, Shah PP, Mathur N, Buters J, Pant MC, Parmar D. Genetic polymorphisms in CYP1B1 and susceptability to head and neck cancer. Mutat Res 639,11-9, 2008. (IF 4.11)
44.    Willi R, Pfab F, Huss-Marp J, Buters J, Zilker T, Behrendt H, Ring J, Darsow U. Contact anaphylaxis and protein contact dermatitis in a cook handling chicory leaves. Contact Dermatitis 60, 4.226-227, 2009. (IF 2.45)
45.    Willi R, Felgenhauer N, Eyer F, Buters J, Zilker T: Lead intoxication in a group of workers in Germany. Dtsch Med Wochensch 134; 2556-2560, 2009 (IF 0.3).
46.    Bryce M, Drews O, Schenk MF, Menzel A, Estrella N, Weichenmeier I, Smulders, MJ, Buters J, Ring J, Gorg A, Behrendt H, Traidl-Hoffmann C. Impact of Urbanization on the Proteome of Birch Pollen and Its Chemotactic Activity on Human Granulocytes. Int Arch Allergy Immunol 2010;151(1):46-55.  (IF 2.7)
47.    Chen W, Beck I, Schober W, Brockow K, Effner R, Buters JT, et al. Human mast cells express androgen receptors but treatment with testosterone exerts no influence on IgE-independent mast cell degranulation elicited by neuromuscular blocking agents. Exp Dermatol 19; 302-304, 2010 (IF 3.2).
48.    Lubitz S, Schober W, Pusch G, Effner R, Klopp N, Behrendt H, Buters J. Polycyclic aromatic hydrocarbons from diesel emissions exert proallergic effects in birch pollen allergic individuals through enhanced mediator release from basophils. Environmental Toxicology, 25; 188-197, 2010 (IF 1.6)
49.    Braun A, Bewersdorff M, Lintelmann J, Matuschek G, Jakob T, Gottlicher M, Schober, W, Buters, J, Behrendt, H, Mempel, M. Differential impact of diesel particle composition on pro-allergic dendritic cell function. Toxicol Sci 113; 85-94, 2010 (IF 4.4) .
50.    Schober W, Pusch G, Oeder S, Reindl H, Behrendt H, Buters J: Metabolic activation of phenanthrene by human and mouse cytochromes P450 and pharmacokinetics in CYP1A2 knockout mice. Chem Biol Interact 2010; 183:57-66, 2010. (IF 3.1).
51.    Buters J, Weichenmeier I, Kreyling W, Boere J,  Schober W, and Behrendt H: Concentration of the major birch pollen allergen Bet v 1 in different fractions of ambient air deviates from pollen counts in Munich, Germany. Allergy 65; 850-8, 2010 (IF 6.2).
52.    Reichl FX, Seiss M, Buters J, Behrendt H, Hickel R, Durner J: Expression of CYP450-2E1 and formation of 2,3-epoxymethacrylic acid (2,3-EMA) in human oral cells exposed to dental materials. Dent Mater 26:1151-6, 2010 (IF 2.4)
53.    Roedl D, Oji V, Buters J, Behrendt H, Braun-Falco M: rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients, J Dermatol Sci , 61,3,194-8 2011 (IF 3.7)
54.    Willi RF, Pfab F, Zilker T, Buters J, Schalock P, Huss-Marp J, Ring J, Darsow U: Danger from the workplace: allergic contact dermatitis at the first exposure to isothiazolinone? Contact Dermatitis, 64(6): 361-362, 2011 (IF 3.6)
55.    Oeder S, Dietrich S, Weichenmeier I, Schober W, Pusch G, Jorres RA, Schierl R, Nowak D, Fromme H, Behrendt H, Buters JT. Toxicity and elemental composition of particulate matter from outdoor and indoor air of elementary schools in munich, germany. Indoor Air 2012;22:148-158. (IF 2.0)
56.    Buters J, Thibaudon M, Smith M, Kennedy R, Rantio-Lehtimäki A, Albertini R, Reese G, Weber BM, Galan C, Brandao R, Antunes CM, Jäger S, Berger U, Celenk S, Grewling L, Jackowiak B, Sauliene I, Weichenmeier I, Pusch G, Sarioglu H, Ueffing M, Behrendt H, Prank M, Sofiev M, Cecchi L. Release of bet v 1 from birch pollen from 5 european countries. Results from the hialine study. Atmos Environ 2012;55:496-505 (IF 3.3).
57.    Buters J. Automatische Pollenzählung: Das Warnsystem der Zukunft für Pollenallergiker“. Allergo J 21; 366-367, 2012 (IF 0.3)
58.    Jochner S, Ziello C, Böck A, Estrella N, Buters J, Weichenmeier I, Behrendt H, Menzel A. Spatio-temporal investigation of flowering dates and pollen counts in the topographically complex zugspitze area on the german-austrian border. Aerobiologia 28:541-556, 2012 (IF 1.5)
59.    Öder S, Fromme H, Dietrich S, Lintelmann J, Jörres R, Schielr R, Behrendt H, Buters J: Differential gene expression of inflammatory and xenobiotic metabolizing genes after exposure to elementary indoor/outdoor PM10. (in press, American Journal of Respiratory Cell and Molecular Biology 2012. (IF 5.1).
60.    Papadopoulos NG, Agache I, Bavbek S, Bilo BM, Braido F, Cardona V, Custovic A, Demonchy J, Demoly P, Eigenmann P, Gayraud J, Grattan C, Heffler E, Hellings PW, Jutel M, Knol E, Lotvall J, Muraro A, Poulsen LK, Roberts G, Schmid-Grendelmeier P, Skevaki C, Triggiani M, Vanree R, Werfel T, Flood B, Palkonen S, Savli R, Allegri P, Annesi-Maesano I, Annunziato F, Antolin-Amerigo D, Apfelbacher C, Blanca M, Bogacka E, Bonadonna P, Bonini M, Boyman O, Brockow K, Burney P, Buters J, Butiene I, Calderon M, Cardell LO, Caubet JC, Celenk S, Cichocka-Jarosz E, Cingi C, Couto M, Dejong N, Del Giacco S, Douladiris N, Fassio F, Fauquert JL, Fernandez J, Rivas MF, Ferrer M, Flohr C, Gardner J, Genuneit J, Gevaert P, Groblewska A, Hamelmann E, Hoffmann HJ, Hoffmann-Sommergruber K, Hovhannisyan L, Hox V, Jahnsen FL, Kalayci O, Kalpaklioglu AF, Kleine-Tebbe J, Konstantinou G, Kurowski M, Lau S, Lauener R, Lauerma A, Logan K, Magnan A, Makowska J, Makrinioti H, Mangina P, Manole F, Mari A, Mazon A, Mills C, Mingomataj EC, Niggemann B, Nilsson G, Ollert M, O'Mahony L, O'Neil S, Pala G, Papi A, Passalacqua G, Perkin M, Pfaar O, Pitsios C, Quirce S, Raap U, Raulf-Heimsoth M, Rhyner C, Robson-Ansley P, Alves RR, Roje Z, Rondon C, Rudzeviciene O, Rueff F, Rukhadze M, Rumi G, Sackesen C, Santos AF, Santucci A, Scharf C, Schmidt-Weber C, Schnyder B, Schwarze J, Senna G, Sergejeva S, Seys S, Siracusa A, Skypala I, Sokolowska M, Spertini F, Spiewak R, Sprikkelman A, Sturm G, Swoboda I, Terreehorst I, Toskala E, Traidl-Hoffmann C, Venter C, Vlieg-Boerstra B, Whitacker P, Worm M, Xepapadaki P, Akdis CA. Research needs in allergy: An eaaci position paper, in collaboration with efa. Clinical and translational allergy 2012;2:21.  (IF3.8)
61.    Peters LM, Demmel S, Pusch G, Buters J, Leeb T, Thormann W, Zielinski J, Mevissen M, Schmitz A, Equine Cytochrome P450 2B6 - Genomic Identification, Expression and Functional Characterization with Ketamine. Toxicol Appl Pharmacol 2013 (IF 4.4).
62.    Zirbs M, Pürner C, Buters J, Effner R, Weidinger S, Ring J, et al. GSTM1, GSTT1 and GSTP1 Gene Polymorphism in Polymorphous Light Eruption. J Eur Acad Dermatol, in press 2013 (IF 3.0)
63.    Airborne olive pollen counts are not representative of exposure to the major olive allergen Ole e 1. Carmen Galan, Celia Antunes, Rui Brandao, Carmen Torres, Herminia Garcia-Mozo, Elsa Caeiro, Raquel Ferro, Marje Prank, Mikhial Sofiev, Roberto Albertini, Uwe Berger, Lorenzo Cecchi, Sevcan Celenk, Łukasz Grewling, Bogdan Jackowiak, Siegfried Jäger,Roy Kennedy, Auli Rantio-Lehtimäki, Gerald Reese, Ingrida Sauliene, Matt Smith, Michel Thibaudon, Bernhard Weber, Ingrid Weichenmeier, Gudrun Pusch1, Jeroen T.M. Buters. Allergy 68(6): 809-812, 2013 (IF 6.3).
64.    Behrendt H, Alessandrini F, Buters J, Krämer U, Koren H, Ring J. Environmental pollution and allergy: historical aspects. In: History of Allergy, Karger 2013 (IF 0.3)
65.    O´Connor D, Healy DA, Hellebust S, Buters J, Sodeau J. Using the WIBS-4 (Waveband Integrated Bioaerosol Sensor) technique for the on-line detection of pollen grains. Aerosol Science & Technology 2013. In press IF 2.8
66.    De Weeger, LA, Bergmann KC, Rantion-Lehtimaaki A, Dahl A, Buters J et al. Impact of pollen. In:„Allergenic Pollen“ eds. Sofiev M and Bergman KC, Springer Verlag, Heidelberg 2013
67.    Beck I, Jochner S, Gilles, S, McIntyre M, Buters J, Behrendt H, Ring J, Menzel A, Schmidt-Weber C, Traidl-Hoffmann,C. High environmental ozone levels lead to enhanced allergenicity of birch pollen. PLOS1 in press. 2013. (IF 4.1)
68.    Buters J, Cecchi L and Albertini R. The EU-HIALINE network for allergen monitoring in ambient air. European Journal of Aerobiology and Environmental Medicine, 10; 15-16, 2014 (IF 0.3) 
69.    Raulf, M., J. Buters, M. Chapman, L. Cecchi, F. de Blay, G. Doekes, et al. European Academy of and I. Clinical. "Monitoring of occupational and environmental aeroallergens-- EAACI Position Paper. Concerted action of the EAACI IG Occupational Allergy and Aerobiology & Air Pollution." Allergy 69(10): 1280-1299.2014 (IF 5.9).
70.    Buters J. Pollen allergens and geographical factors. In: Global Atlas of Allergy, Eds. Akdis C and Agache I. EAACI p36-38, 2014 (IF 0.3)
71.    Haberle SG, Bowman D M, Newnham RM, Johnston FH, Beggs PJ, Buters J et al. The macroecology of airborne pollen in Australian and New Zealand urban areas . PLOS One, 9 (5) e97925. 2014 (IF 3.2).
72.    Behrendt H, Alessandrini F, Buters J, Kramer U, Koren H, Ring J. Environmental pollution and allergy: historical aspects. Chem Immunol Allergy 100, 268-277, 2014 (IF 0.3)
73.    Ring J, Akdis C, Lauener R, Schäppi G, ...Buters J,.et al. Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure--challenges and actions to be taken. Allergy 69, 8,978-82, 2014 (IF 6.0)
74.    Buters J, Prank, M., Sofiev, M., Pusch, G., Albertini, R., Annesi-Maesano, I., Antunes, C., Behrendt, H., Berger, U., Brandao, R., Celenk, S., Galan, C., Grewlinh, L., Jackowiak, B., Kennedy, R., Rantio-Lehtimaaki, A., Reese, G., Sailine, I., Smith, M., Thibaudon, M., Weber, B., and Cecchi, L. Variation of the group 5 grass pollen allergen content of airborne pollen in relation to geographical location and time in season. J Allergy Clin Immunol, 136,87-95, 2015 (IF 12.5).
75.    Buters J, Alberternst B, Nawrath S, Traidl-Hoffmann C, Starfinger U, Behrendt H, Schmidt-Weber C, Bergman KC. Ambrosia artemisiifolia (Ragweed) in Germany – current presence, allergological relevance and containment procedures. Allergo J Int, 24, 109-120, 2015 (IF N.A.)
76.    Eberlein B, Hann R, Eyerich S, Pennino D, Ring J, Schmidt-Weber C, and  Buters J. Optimizing of the basophil activation test: comparison of different basophil identification markers. Cytometry Part B- Clinical Cytometry 88, 3, 183-9, 2015 (IF 2.3)
77.    Oteros-Moreno J, Pusch G, Weichenmeier I, Heimann U, Moeler R, Traidl-Hoffmann C, Schmidt-Weber C, Buters J. Automatic and on-line Pollen monitoring. Int Arch Allergy Immunol, 167, 158-166, 2015 (IF 2.7)
78.    Oeder S, Alessandrini F, Wirz OF, Braun A,Wimmer M, Frank U, Hauser M, Durner J, Ferreira F, Ernst D, Mempel M, Gilles S, Buters J, Behrendt H, Traidl-Hoffmann C, Schmidt-Weber C, Akdis M, Gutermuth J. Pollen-derived nonallergenic substances enhance Th2-induced IgE production in B cells. Allergy 2015 (IF 6.03) , DOI: 10.1111/all.12707
79.    Oeder S, Kanashova T, SippulaO, Sapcariu SC, Streibel T, Arteaga-Salas JM, Passig J, Dilger M, Paur HR, Schlager C, Mulhopt S, Diabate S, Weis C, Stengel M, Tiggesbaumker J, Karg E, Jacobi G, Scholtes S, Schnelle-Kreis J, Lintelman J, Matuschek G, Sklorz M, Klingbeil S, Orasche J, Richthammer P, Müller L, Elsasser M, Reda A, Groger T, Weggler B, Schwemer T, Czech H, Ruger CP, Abbaszade G, Radichat C, Hiller C, Buters J, Dittmar G, Zimmermann R. Particulate matter from both heavy fuel oil and diesel fuel shipping emissions show strong biological effects on human lung cells at realistic and comparable in vitro exposure conditions. PloSOne 10, e0126536, 2015 (IF 3.23)
80.    D´Amato G, Holgate S, Pawankar R, Ledford DK, Cecchi L, Al-Ahmad M....Buters J....Annesi-Maesano I. Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization.  World Allergy Organ J, 8, 25, 2015 (IF 5.6)
81.    Jochner S, Luepke M, Laube J, Weichenmeier I, Pusch G, Traidl-Hoffmann C, Schmidt-Weber C, Buters J and Menzel A. Seasonal variation of birch and grass pollen loads and allergen release at two sites in the German Alps. Atmos Environ 122: 83-93, 2015 (IF 3.3)
82.    Buters J. Review: Pollen, allergens, molds and bacteria in ambient air. Allergologie 38, 1-7, 2015 (IF 0.3)
83.    Behrendt H, Krämer U, Buters J and Ring J. Chapter 4: Allergie und Umwelt. In: Allerglogie, eds Biedermann T et al., Springer Berlin 2015. (IF 0.3)
84.    Buters J. Chapter 5: Impacts of climate change on allergenicity. In: Impacts of climate change on allergens and allergic diseases, eds. P. Beggs. Cambridge University Press, 2016 (IF 0.3)
85.    Pfaar, O., K. Bastl, U. Berger, J. Buters, M. A. Calderon, B. Clot, U. Darsow, P. Demoly, S. R. Durham, C. Galan, R. Gehrig, R. Gerth van Wijk, L. Jacobsen, L. Klimek, M. Sofiev, M. Thibaudon and K. C. Bergmann. Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI Position Paper."Allergy. 2016 (IF 6.03)
86.    Eberlein , Buters 2014  alpine clinical translational allergy
87.    Bastl K, Kmenta M, Pessi AM, Prank M, Saarto A, Sofiev M, Bergmann KC, Buters J, Thibaudon M, Jäger S, Berger U. First comparison of symptom data with allergen content (bet v 1 and phl p 5 measurements) and pollen data from four european regions during 2009-2011. Sci Total Environ  548-549:229-235, 2016. (IF 4.0)
88.    Haberle SG, Bowman DM, Newnham RM, Johnston FH, Beggs PJ, Buters J, et al. The macroecology of airborne pollen in australian and new zealand urban areas. PLoS One 9:e97925, 2014. (IF 3.2)
89.    Buters J. An allergy friendly urban environment. Allergologie, Jahrgang 39, Nr. ■00■/2016, S. 18, (IF 0.3)
90.    B, Rabe R, Harndorf H, Torvela T, Jikiniemi J, Hirvonen MR, Traidl-Hoffmann C, Berube KA, Wlodarczyl AJ, Orytherch Z, Michalke B, Krebs T, Prevot AS, Kelbg 
91.    Buters J. Impacts of climate change on allergenicity. In: Impacts of climate change on allergens and allergic diseases, Ed. Beggs P. Cambridge Press, Cambridge 2016. (IF 0.3)
92.    Buters J. Online Pollen monitoring. Basiswissen Allergie, Springer Verlag Berlin, 2016 (IF 0.3).
93.    Sapcariu SC, Kanshova T, Dilger M, Diabate S, Oeder S, Passig J, Radischal C, Buters J et al. Metabolic Profiling as Well as Stable Isotope Assisted Metabolic and Proteomic Analysis of RAW 264.7 Macrophages Exposed to Ship Engine Aerosol Emissions: Different Effects of Heavy Fuel Oil and Refined Diesel Fuel. PloS One 11:6-32, e0157964, 2016 (IF 3.5)
94.    Müllhopt S, Dilger M, Diabate S, Schlager C, Krebs T, Zimmermann R, Buters J, Oeder S, Wäscher T, Weis C, Paur HP. Toxicity testing of combustion aerosols at the air–liquid interface with a self-contained and easy-to-use exposure system. J Aerosol Sci 96:38-55, 2016 (IF 1.2)
95.    Effner, R., J. Hiller, S. Eyerich, C. Traidl-Hoffmann, K. Brockow, M. Triggiani, H. Behrendt, C. B. Schmidt-Weber and J. T. Buters. Cytochrome P450s in human immune cells regulate IL-22 and c-Kit via an AHR feedback loop. Sci Rep 7: 44005, 2017. IF 4.3
96.    Oteros J, Buters J, Laven G, Röseler S, Wachter R, Schmidt-Weber C, Hoffmann F. Flow measurements of Hirst-type pollen monitors. Aerobiologia 2017, DOI 10.1007/s10453-016-9467-x (IF 1.7)
97.    Buters, J. and T. Biedermann (2017). "Chromium(VI) Contact Dermatitis: Getting Closer to Understanding the Underlying Mechanisms of Toxicity and Sensitization!" J Invest Dermatol 137: 274-276. 2017 (IF 6.9).
98.    Pfaar, O., K. Bastl, U. Berger, J. Buters, M. A. Calderon, B. Clot, U. Darsow, P. Demoly, S. R. Durham, C. Galan, R. Gehrig, R. Gerth van Wijk, L. Jacobsen, L. Klimek, M. Sofiev, M. Thibaudon and K. C. Bergmann. "Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper." Allergy 72(5): 713-722, 2017 (IF 7.4)
99.    Buters J. Pollen und Pollenwarndienste. In Handbuch Umweltmedizin, eds Wichmann und Fromme, Ecomed 2017 (IF 0.3).
100.    Gruber B, Schneider J, Buters J, Zimmermann R, Matuschek G. A minimal-invasive method for systemic bio-monitoring of the environmental pollutant phenanthrene in humans: Thermal extraction and gas chromatography - mass spectrometry from 1 μL capillary blood. J Chromatogr A, doi:10.1016/j.chroma.2017.01.045, 2017 (IF 3.2)
101.    Oteros J, Bartusel E1, Núñez-Hernández A, Moreno-Gómez D, Behrendt H, Schmidt-Weber C, Traidl-Hoffmann C, Buters J. Artemisia pollen is the main vector for airborne endotoxin., J Allergy Clin Immunol, doi.org/10.1016/j.jaci.2018.05.040 2018 (IF 13.1)
102.    Buters, J. Kapitel IV. Pollen und Pollenwarndienste. In Wichmann und Fromme, Eds. Ecomed 2018 (IF 0.3)
103.    Buters J, Antunes C, Galveias A, Bergmann KC, Thibaudon M, Galan C, Schmidt-Weber C, Oteros J: Pollen and Spore Monitoring in the world. Clin Trans Allergy 8; 9-13, 2018 (IF 3.2)
104.    Kanashova T, Sippula O, Sebastian Oeder S…Buters J, Ditttmar G, Zimmermann R. Emissions from a modern log wood masonry heater and wood pellet boiler: Composition and biological impact on air-liquid interface exposed human lung cancer cells. J Molec Clin Med 1; 23-35, 2018.
105.    Buters J, Schmidt-Weber C, Oteros J. Next generation pollen monitoring and dissemination. Allergy 2018, in press (IF 6.0)

Contact

Prof. Dr. rer. pharm. Jeroen Buters

Zentrum Allergie und Umwelt (ZAUM)
Technische Universität und Helmholtz Zentrum München

Biedersteiner Str. 29
80802 München

Phone: +49 89 4140-3487
E-mail:
 

Curriculum Vitae

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Only cookies permitted that are required for the basic functionality of our websites.
Permit cookies that help us to analyse the page views and user behavior on our websites. We only use this information for improving our services.
Permit embedded content and cookies from third party providers. This setting enables the full use of our web services (e.g. displaying videos).
Please find more information in our privacy statement.

There you may also change your settings later.